A former advertising technology executive at News Corp testified that the company considered moving away from Google’s advertising products in 2017 but ultimately decided against it due to potential revenue losses of at least $9 million. The testimony came during the second day of the latest antitrust trial exploring Google’s absolute dominance of the internet.
The New York Post reports that during the second day of the Justice Department’s antitrust case against Google, Stephanie Layser, a former advertising technology executive at News Corp, took the stand to shed light on the tech giant’s dominance in the digital advertising market. Layser, who worked at News Corp from 2017 to 2022, revealed that despite Google’s advertising tools being “clunky and slow” and the company’s reluctance to add new features, News Corp felt compelled to continue using their services due to Google’s market control.
Layser’s testimony highlighted the extent of Google’s stranglehold on the digital advertising industry, with the former executive stating, “I felt like they were holding us hostage.” She explained that Google’s ad exchange was essentially the only service publishers used for ad deals, leaving companies like News Corp with few alternatives.
According to court documents, News Corp earned $83.3 million in ads sold through digital ad tech tools in 2016, with the majority of deals utilizing Google’s ad exchange and generating $18.4 million in revenue from advertisers active on the platform. When exploring the possibility of leaving Google’s ecosystem, News Corp estimated that roughly half of the $18.4 million came from advertisers exclusive to Google’s network, meaning the news giant would lose more than $9 million if they discontinued using Google’s services. […]
— Read More: www.breitbart.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
